BNET Industries

Market Cap:$5.1M
Last Fiscal Year Sales:$74.9M
  • Public
  • US
Dow Jones Description

We are a life sciences organization focused on providing our clients with solutions to complex needs in clinical research and regulatory compliance. Our strengths are derived from a solid foundation of forward thinking and continuous investment in training and research. We serve a variety of clients, including those in the private industry, public institutions, research facilities and the government. By focusing on specialized practice areas in regulatory compliance, clinical research, and international development of global health and advanced technology research, we are able to offer solutions with one common goal in mind, to improve the human condition by delivering forward thinking solutions to the global community. (ii) Principal Products, Services, and Principal Markets IT&E is a leading provider of a broad range of services to the Life Sciences Industries. We primarily provide our clients with solutions to complex needs in clinical research and regulatory compliance.

Number of Employees 440
Contact Information

225 Turnpike Road

Southborough, Massachusetts 01772

www.averionintl...

(508) 597-6000

NAICS Code : 541710

Recent Events

  • ProChon Biotech Selects Averion International for the BioCartâ„¢ Cartilage Regeneration System Study

    8/03/09 - Licensing / Contract - View Story

Decision Makers

Name (plus bio) Position
Markus H. Weissbach CEO
Lawrence R. Hoffman CFO
Peter C. Gonze Executive Vice President, Global Business Dev
Alison Messom Head, Global Project Mgmt

Board of Directors

Name (plus bio) Position
Michael S. Falk Chairman
Philip T. Lavin Chairman
Alastair McEwan Board of Directors
Cecilio M. Rodriguez Board of Directors
Fred Sancilio Board of Directors
James Powers Board of Directors
Robert D. Tucker Board of Directors

Dr Markus H. Weissbach, MD, Board Member, is Chief Executive Officer of Hesperion AG in Allschwil, Switzerland. Dr Weissbach has more than 20 years experience in international drug development and a track record of several successful NDAs. After 6 years of practicing medicine in cardiology, surgery and intensive care, he held executive positions at Knoll AG, Takeda Euro R&D Ltd and Icon plc.

Organization Position Status
Hesperion AG Chief Executive Officer Current
Averion International Corp. CEO Current
Vasopharm Board Member Current
Hesperion AG COO Former

Organization Position Status
Averion International Corp. CFO Current

Organization Position Status
Averion International Corp. Executive Vice President, Global Business Dev Current

Organization Position Status
Averion International Corp. Head, Global Project Mgmt Current

Organization Position Status
Commonwealth Associates Group Holdings, LLC Founder Current
ComVest Investment Partners II, LLC Managing Partner Current
Comvest, Ltd. Managing Partner Current
Comvest Investment Partners LLC Managing Partner Current
Averion, Inc Chairman, Director Current
Averion International Corp. Chairman Current
Comvest Group, Inc. Chairman Current
Comvest, Ltd. Chairman Current
Comdial Corporation Chairman Current
Comvest Investment Partners LLC Chairman of Averion's Board of Directors Current
Comdial Corporation Director Current
Allegiant Air Director Current
MedAvant Healthcare Solutions Director Current
The Care Fund Board Member Current
Catalyst International, Inc. Board Member Current
The Care Fund Member Current
Catalyst International, Inc. Member Current
Allegiant Air Member Current
Commonwealth Associates Group Holdings, LLC Chairman, President & CEO Former
Commonwealth Associates, Inc. Co-Founder Former
PlanVista Corporation Director Former
Queens College B.A. Degree In Economics Former
Stanford University B.A. Degree In Economics Former

Organization Position Status
Averion International Corp. Chairman Current
Averion International Corp. Board of Directors Current

Organization Position Status
Averion International Corp. Board of Directors Current

Organization Position Status
Averion International Corp. Board of Directors Current

Organization Position Status
Averion International Corp. Board of Directors Current
Averion International Corp. Vice Chairman Current

Organization Position Status
Averion International Corp. Board of Directors Current

Organization Position Status
Averion International Corp. Board of Directors Current
advertisement
     AVRO $0.01 -0.00 (-1.28% )
Average Volume 202,440
Shares Outstanding 639.26M
Market Cap 4.9M
Year High 0.08
Year Low 0.004
Earnings Per Share -0.05
P/E Ratio -0.15
Dividend N/A
Yield N/A
advertisement